Parkinson's disease is a progressive and common neurodegenerative condition, typically characterized by involuntary shaking, stiffness, and slow movement. Beyond these motor symptoms, individuals ...

Movement disorders are a group of neurological syndromes in which the hallmark symptom is paucity of movement, excessive and/or involuntary movement or tremor. Movement disorders can be ...

The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, ...

REM Sleep Behavior Disorder causes more than dream enactment—it’s a powerful clue to neurodegenerative disease risk.

Neuromodulation has revolutionized the treatment of movement disorders such as Parkinson’s disease, dystonia, and essential tremor. With advancements in ...

Research from Martin Luther University suggests the asthma drug theophylline helps reduce symptoms in ADCY5-related ...

which undertakes world-leading basic and clinical research across the spectrum of movement disorders, their causes, and treatments. The MDC is a hub for clinical and research excellence across a range ...

Ariya, who’s is three, has a diagnosis of spastic quadriplegic cerebral palsy and dystonia – both movement disorders. “She cannot sit unassisted; she cannot walk like a regular toddler can; [and] she ...

—According to new research, oral vertical dyskinesia (OVD), also known by the older term “rabbit syndrome,” may be part of a spectrum of symptoms of drug-induced parkinsonism and tardive ...

Sleep disorders may lead to structural brain changes, cognitive decline, and neurological disease. Here’s what science says about the risk.

Series A led by Atlas Venture, and founded by an expert team of physicians and scientists - VIM0423, a potential first-in-class oral medicine for isolated dystonia, is currently being studied in a ...